Ticker AERI – Aerie Pharmace – sales, description, marketcap – Tickerday.com

AERI

Aerie Pharmace

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 541.43M; Volume: 102.28K; AvgVol 3m: 710.86K; Beta: 0.81;

Cost estimate:

P/E: –; EPS: -4.42; EPS growth quarter/prev quarter: -1.10%;

EPS growth this year: 21.30%; EPS growth past 5 years: -17.10%;

EPS ttm: -4.42;

P/S: 6.79; P/B: 6.14; P/Cashflow: 2.29; P/FCF: ;

Sales: 81.57M; Sales growth quarter/prev quarter: 13.90%; Sales growth past 5 years: ;

Profitability:

Gross Margin: 79.00%; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -46.70%; ROE – return on equity: -136.10%; LT Debt/Equity: 2.22; Total Debt/Equity: 2.22;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 1.60%; Insider Transactions:-0.67%;

Institutional Ownership: ; Institutional Transactions: -6.15%;

Data update: 07.10.2020.